Ticker Symbol: ODTC
Odonate Therapeutics Inc
Exchange: OTC MARKETS
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001717452
Company Profile
Odonate Therapeutics, Inc. is a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Odonate’s initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are widely used in the treatment of cancer. Odonate’s goal for tesetaxel is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 4747 Executive Dr
Website: www.odonate.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $1.50 - $1.80
Beta: -
52wk. High: $4,840.00
52wk. Low: $3,000.00
Ytd. Change -14.29%
50 Day Moving Average: $3,000.00
200 Day Moving Average: $3,377.08
Shares Outstanding: 28529414
Valuation
Market Cap: 4.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A